158 related articles for article (PubMed ID: 7539400)
1. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen.
Karsten U; Butschak G; Cao Y; Goletz S; Hanisch FG
Hybridoma; 1995 Feb; 14(1):37-44. PubMed ID: 7539400
[TBL] [Abstract][Full Text] [Related]
2. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta.
Richter DU; Jeschke U; Makovitzky J; Goletz S; Karsten U; Briese V; Friese K
Anticancer Res; 2000; 20(6D):5129-33. PubMed ID: 11326683
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody BW835 defines a site-specific Thomsen-Friedenreich disaccharide linked to threonine within the VTSA motif of MUC1 tandem repeats.
Hanisch FG; Stadie T; Bosslet K
Cancer Res; 1995 Sep; 55(18):4036-40. PubMed ID: 7545084
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
[TBL] [Abstract][Full Text] [Related]
6. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen.
Hanisch FG; Baldus SE
Histol Histopathol; 1997 Jan; 12(1):263-81. PubMed ID: 9046061
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of MUC1 mucin peptide core and the Thomsen-Friedenreich antigen in colorectal neoplasms.
Baldus SE; Hanisch FG; Kotlarek GM; Zirbes TK; Thiele J; Isenberg J; Karsten UR; Devine PL; Dienes HP
Cancer; 1998 Mar; 82(6):1019-27. PubMed ID: 9506345
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
9. The Potential Action of Thomsen-Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer.
Peng Y; Zhan XX; Cao Y; Zhang HW; Cao WH; Su YJ; Diao C; Sun QM; Cheng RC
Onco Targets Ther; 2020; 13():8677-8689. PubMed ID: 32982276
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharide Gal beta 1-3GlcNAc.
Rye PD; Bovin NV; Vlasova EV; Walker RA
Glycobiology; 1995 Jun; 5(4):385-9. PubMed ID: 7579792
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of monoclonal antibody to T-antigen: (gal beta1-3GalNAc-alpha-O).
Rittenhouse-Diakun K; Xia Z; Pickhardt D; Morey S; Baek MG; Roy R
Hybridoma; 1998 Apr; 17(2):165-73. PubMed ID: 9627057
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody.
Shigeoka H; Karsten U; Okuno K; Yasutomi M
Tumour Biol; 1999; 20(3):139-46. PubMed ID: 10213921
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
14. Novel immunogenicity of Thomsen-Friedenreich disaccharide obtained by a molecular rotation on its carrier linkage.
Irazoqui FJ; Lopez PH; Vides MA; Nores GA
Glycobiology; 2000 Aug; 10(8):781-7. PubMed ID: 10929004
[TBL] [Abstract][Full Text] [Related]
15. Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen.
Dahlenborg K; Hultman L; Carlsson R; Jansson B
Int J Cancer; 1997 Jan; 70(1):63-71. PubMed ID: 8985092
[TBL] [Abstract][Full Text] [Related]
16. Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody.
Jeschke U; Karsten U; Wiest I; Schulze S; Kuhn C; Friese K; Walzel H
Histochem Cell Biol; 2006 Oct; 126(4):437-44. PubMed ID: 16607538
[TBL] [Abstract][Full Text] [Related]
17. Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study.
Cao Y; Stosiek P; Springer GF; Karsten U
Histochem Cell Biol; 1996 Aug; 106(2):197-207. PubMed ID: 8877380
[TBL] [Abstract][Full Text] [Related]
18. Tumor immunolocalization using 124 I-iodine-labeled JAA-F11 antibody to Thomsen-Friedenreich alpha-linked antigen.
Chaturvedi R; Heimburg J; Yan J; Koury S; Sajjad M; Abdel-Nabi HH; Rittenhouse-Olson K
Appl Radiat Isot; 2008 Mar; 66(3):278-87. PubMed ID: 17890096
[TBL] [Abstract][Full Text] [Related]
19. Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen.
Stein R; Chen S; Grossman W; Goldenberg DM
Cancer Res; 1989 Jan; 49(1):32-7. PubMed ID: 2461799
[TBL] [Abstract][Full Text] [Related]
20. Correlative fine specificity of several Thomsen-Friedenreich disaccharide-binding proteins with an effect on tumor cell proliferation.
Irazoqui FJ; Jansson B; Lopez PH; Nores GA
J Biochem; 2001 Jul; 130(1):33-7. PubMed ID: 11432777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
